Day One Biopharmaceuticals, Inc. - Common Stock (NQ:DAWN)

21.47 -0.02 (-0.09%)

Streaming Delayed Price Updated: 11:17 AM EDT, Apr 14, 2026 Add to My Watchlist

Price and Volume

Volume	161,182
Open	21.47
Bid (Size)	21.47 (9,700)
Ask (Size)	21.48 (10,100)
Prev. Close	21.49
Today's Range	21.47 - 21.48
52wk Range	5.635 - 21.49
Shares Outstanding	73,572,633
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Terns Therapeutics, Inc. (Nasdaq – TERN), Whitestone REIT (NYSE – WSR), Rallybio Corporation (Nasdaq – RLYB), Day One Biopharmaceuticals, Inc. (Nasdaq - DAWN)

April 09, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

March 26, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Performance

YTD	+142.6%	+142.6%
1 Month	+0.5%	+0.5%
3 Month	+89.5%	+89.5%
6 Month	+198.6%	+198.6%
1 Year	+197.4%	+197.4%

More News

Halper Sadeh LLC is Investigating Whether DAWN, SEM, EWCZ, FONR are Obtaining Fair Deals for their Shareholders

March 12, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Day One Biopharmaceuticals Inc (NASDAQ:DAWN) Reports Q4 Revenue Beat but Wider Loss, Shares Dip ↗

February 24, 2026

Via Chartmill

Halper Sadeh LLC is Investigating Whether DAWN, KORE, CECO are Obtaining Fair Deals for their Shareholders

March 10, 2026

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Talkspace, Inc. (Nasdaq - TALK), Day One Biopharmaceuticals, Inc. (Nasdaq - DAWN), Kennedy-Wilson Holdings, Inc. (NYSE - KW), United Homes Group, Inc. (Nasdaq - UHG)

March 09, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

The $12.3 Billion Dawn: A Comprehensive Research Feature on Dayforce Inc. (DAWN)

March 09, 2026

Via Finterra

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

March 06, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Stock Market Today, March 6: Energy Stocks Rise as Oil Closes Over $90 on Middle East Tensions ↗

March 06, 2026

Via The Motley Fool

Here are the top movers in Friday's session. ↗

March 06, 2026

Via Chartmill

Which stocks are moving on Friday? ↗

March 06, 2026

Via Chartmill

DAWN Stock Alert: Halper Sadeh LLC is Investigating Whether Day One Biopharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders

March 06, 2026

From Halper Sadeh LLC

Via Business Wire

The market is filled with gapping stocks in Friday's session. ↗

March 06, 2026

Via Chartmill

Why Did DAWN Skyrocket Over 65% Pre-Market Today? ↗

March 06, 2026

Via Stocktwits

Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio

March 06, 2026

From Day One Biopharmaceuticals, Inc.

Via GlobeNewswire

DAWN Shares Rally On Buyout Speculation But Retail Warns A Deal Might Not Materialise ↗

March 04, 2026

Via Stocktwits

Day One Bio (DAWN) Q4 2025 Earnings Transcript ↗

February 24, 2026

Via The Motley Fool

Day One Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Outlook and Revenue Guidance

February 24, 2026

From Day One Biopharmaceuticals, Inc.

Via GlobeNewswire

Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026

February 10, 2026

From Day One Biopharmaceuticals, Inc.

Via GlobeNewswire

AIGH Capital Dumps 2.6 Million Lumen Technologies Shares In $15.6 Million Exit ↗

February 03, 2026

Via The Motley Fool

Keep an eye on the top gainers and losers in Monday's session. ↗

January 12, 2026

Via Chartmill

Gapping stocks in Monday's session ↗

January 12, 2026

Via Chartmill

Top movers in Monday's pre-market session ↗

January 12, 2026

Via Chartmill

Day One Announces Preliminary 2025 OJEMDA™ Net Product Revenue And Provides 2026 Net Product Revenue Guidance

January 11, 2026

From Day One Biopharmaceuticals, Inc.

Via GlobeNewswire

Curious about the stocks that are showing activity after the closing bell on Friday? ↗

January 09, 2026

Via Chartmill

Frequently Asked Questions

Is Day One Biopharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Day One Biopharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Day One Biopharmaceuticals, Inc. - Common Stock trade on?

Day One Biopharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Day One Biopharmaceuticals, Inc. - Common Stock?

The ticker symbol for Day One Biopharmaceuticals, Inc. - Common Stock is DAWN on the Nasdaq Stock Market

What is the current price of Day One Biopharmaceuticals, Inc. - Common Stock?

The current price of Day One Biopharmaceuticals, Inc. - Common Stock is 21.47

When was Day One Biopharmaceuticals, Inc. - Common Stock last traded?

The last trade of Day One Biopharmaceuticals, Inc. - Common Stock was at 04/14/26 11:17 AM ET

What is the market capitalization of Day One Biopharmaceuticals, Inc. - Common Stock?

The market capitalization of Day One Biopharmaceuticals, Inc. - Common Stock is 1.58B

How many shares of Day One Biopharmaceuticals, Inc. - Common Stock are outstanding?

Day One Biopharmaceuticals, Inc. - Common Stock has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.